LEPIRUDIN Side Effects

6913189-7 | Catheter Site Haematoma, Catheter Site Haemorrhage, Heparin-induced Thrombocytopenia, Tracheal Haemorrhage
on Jul 13, 2010 Male patient from UNITED KINGDOM , 31 years of age, was treated with Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site haematoma, catheter site haemorrhage, heparin-induced thrombocytopenia, tracheal haemorrhage. Lepirudin dosage: .

6671678-7 | Activated Partial Thromboplastin Time Prolonged, Peritoneal Haemorrhage
Patient was taking Lepirudin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, peritoneal haemorrhage on Apr 06, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 199.3 lb, was diagnosed with heparin-induced thrombocytopenia and. Lepirudin dosage: Titrated Per Hour Iv.

6641550-7 | Activated Partial Thromboplastin Time Prolonged, Blood Pressure Abnormal, Haemoglobin Decreased, Oxygen Saturation Abnormal
Adverse event was reported on Mar 17, 2010 by a Female patient taking Lepirudin (View Usage) (Dosage: 0.15mg/kg/hr Continuous Iv Infusion 1/25 0030 - 1/25 0800) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , 75 years of age, weighting 125.7 lb, After Lepirudin was administered, patient had the following side effects: activated partial thromboplastin time prolonged, blood pressure abnormal, haemoglobin decreased, oxygen saturation abnormal. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEPARIN (View Leparin Review and Leparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

6421968-8 | Thrombocytopenia
on Oct 29, 2009 Male patient from UNITED STATES , 56 years of age, weighting 138.6 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Lepirudin dosage: 100 Mg Every Day Iv. Patient was hospitalized.


6248563-8 | Activated Partial Thromboplastin Time Prolonged, Catheter Site Haemorrhage, Haemodialysis, Haemoglobin Decreased, Renal Failure Chronic
on Jun 24, 2009 Male patient from UNITED STATES , 49 years of age, weighting 277.8 lb, was diagnosed with prophylaxis and was treated with Lepirudin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, catheter site haemorrhage, haemodialysis, haemoglobin decreased, renal failure chronic. Lepirudin dosage: 0.002 Mg/kg/hr Iv. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NEPHROCAP (View Nephrocap Review and Nephrocap Label ), INSULIN (View Insulin Review and Insulin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MIDODRINE (View Midodrine Review and Midodrine Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6192382-8 | Hypertonia, Oedema, Proteinuria
Patient was taking Lepirudin (View Usage). After Lepirudin was administered, patient had the following side effects: hypertonia, oedema, proteinuria on May 05, 2009 from UNITED STATES Additional patient health information: Female patient , 21 years of age, was diagnosed with heparin-induced thrombocytopenia and. Lepirudin dosage: . During the same period patient was treated with DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ).

6118896-4 | No Adverse Event
Adverse event was reported on Feb 19, 2009 by a Female patient taking Lepirudin (View Usage) (Dosage: ) was diagnosed with heparin-induced thrombocytopenia and. Location: UNITED STATES , 21 years of age, Patient experienced the following unwanted or unexpected effects: no adverse event.

6114455-8 | Bronchopulmonary Dysplasia
on Feb 19, 2009 Female patient from UNITED STATES , weighting 1.10 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with Lepirudin (View Usage). Patient had the following side effects: bronchopulmonary dysplasia. Lepirudin dosage: .

6045056-8 | Haemoglobin Decreased, Intra-abdominal Haematoma, Pelvic Haematoma
on Jan 15, 2009 Female patient from UNITED STATES , 26 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Lepirudin (View Usage). After Lepirudin was administered, patient had the following side effects: haemoglobin decreased, intra-abdominal haematoma, pelvic haematoma. Lepirudin dosage: . During the same period patient was treated with EPHEDRINE HCL 1PC SOL (View Ephedrine Hcl 1pc Sol Review and Ephedrine Hcl 1pc Sol Label ), ENOXAPARIN SODIUM (Total Daily Dose: 2 Mg/kg) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EPIDURAL ANAESTHESIA (View Epidural Anaesthesia Review and Epidural Anaesthesia Label ), EPOPROSTENOL (View Epoprostenol Review and Epoprostenol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6031194-2 | Intra-abdominal Haematoma, Pelvic Haematoma
Patient was taking Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: intra-abdominal haematoma, pelvic haematoma on Apr 03, 2008 from UNITED STATES Additional patient health information: Female patient , 26 years of age, was diagnosed with pulmonary arterial hypertension and. Lepirudin dosage: . During the same period patient was treated with EPHEDRINE HCL 1PC SOL (View Ephedrine Hcl 1pc Sol Review and Ephedrine Hcl 1pc Sol Label ), ENOXAPARIN SODIUM (Total Daily Dose: 2 Mg/kg) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EPIDURAL ANAESTHESIA (View Epidural Anaesthesia Review and Epidural Anaesthesia Label ), EPOPROSTENOL (View Epoprostenol Review and Epoprostenol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5979904-4 | Haemorrhage, Haemorrhagic Anaemia, Renal Failure Acute, Septic Shock
Adverse event was reported on Jun 06, 2008 by a Female patient taking Lepirudin (View Usage) (Dosage: ) was diagnosed with heparin-induced thrombocytopenia and. Location: FRANCE , 75 years of age, Patient had the following side effects: haemorrhage, haemorrhagic anaemia, renal failure acute, septic shock. During the same period patient was treated with ORGARAN (View Orgaran Review and Orgaran Label ).

5841663-3 | Haemorrhage, Haemorrhagic Anaemia
on Jun 06, 2008 Female patient from FRANCE , 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Lepirudin (View Usage). After Lepirudin was administered, patient had the following side effects: haemorrhage, haemorrhagic anaemia. Lepirudin dosage: . During the same period patient was treated with ORGARAN (View Orgaran Review and Orgaran Label ).

5840435-3 | Haemorrhage, Haemorrhagic Anaemia
on Jun 06, 2008 Female patient from FRANCE , 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, haemorrhagic anaemia. Lepirudin dosage: . During the same period patient was treated with ORGARAN (View Orgaran Review and Orgaran Label ).

5766906-6 | Anaemia, Haemorrhage
Patient was taking Lepirudin (View Usage). Patient had the following side effects: anaemia, haemorrhage on May 30, 2008 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with heparin-induced thrombocytopenia and. Lepirudin dosage: .

5709666-7 | Intra-abdominal Haematoma, Pelvic Haematoma
Adverse event was reported on Apr 03, 2008 by a Female patient taking Lepirudin (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 26 years of age, After Lepirudin was administered, patient had the following side effects: intra-abdominal haematoma, pelvic haematoma. During the same period patient was treated with EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), ENOXAPARIN SODIUM (Total Daily Dose: 2 Mg/kg) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EPIDURAL ANAESTHESIA (View Epidural Anaesthesia Review and Epidural Anaesthesia Label ), EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

5594452-1 | Addison's Disease, Adrenal Haemorrhage, Asthenia, Confusional State, Diarrhoea, Pyrexia
on Jan 03, 2008 Male patient from FRANCE , 33 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: addison's disease (What is addison's disease?), adrenal haemorrhage, asthenia, confusional state, diarrhoea, pyrexia. Lepirudin dosage: .

5426099-1 | Activated Partial Thromboplastin Time Prolonged, Catheter Site Haemorrhage, Condition Aggravated, Haemoptysis
on Aug 23, 2007 Female patient from UNITED STATES , 26 years of age, was treated with Lepirudin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, catheter site haemorrhage, condition aggravated, haemoptysis. Lepirudin dosage: .

5206911-1 | Activated Partial Thromboplastin Time Prolonged, Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Haemoglobin Decreased
Patient was taking Lepirudin (View Usage). After Lepirudin was administered, patient had the following side effects: activated partial thromboplastin time prolonged, blood creatinine increased, creatinine renal clearance decreased, haemoglobin decreased on Jan 05, 2007 from UNITED STATES Additional patient health information: Female patient , 84 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) and. Lepirudin dosage: Varied Iv Inf. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5064238-5 | Cerebral Haemorrhage, Pupil Fixed
Adverse event was reported on Jul 26, 2006 by a Male patient taking Lepirudin (View Usage) (Dosage: Contin Infusion Iv Drip) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 68 years of age, weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, pupil fixed. During the same period patient was treated with ACETAMINOPHEN ALCOHOL FREE (View Acetaminophen Alcohol Free Review and Acetaminophen Alcohol Free Label ), ENTERAL TUBE (View Enteral Tube Review and Enteral Tube Label ), ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (View Albuterol Sulfate And Ipratropium Bromide Review and Albuterol Sulfate And Ipratropium Bromide Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ). Patient was hospitalized.

5015387-9 | Activated Partial Thromboplastin Time Prolonged, Catheter Site Haemorrhage, Confusional State, Epistaxis, International Normalised Ratio Increased, Mouth Haemorrhage
on May 30, 2006 Female patient from UNITED STATES , 88 years of age, was diagnosed with thrombosis and was treated with Lepirudin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, catheter site haemorrhage, confusional state, epistaxis, international normalised ratio increased, mouth haemorrhage. Lepirudin dosage: 0.15mg/kg/hr.

4848052-9 | Cerebral Haemorrhage, Convulsion
on Dec 07, 2005 Female patient from UNITED STATES , 58 years of age, weighting 253.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia and was treated with Lepirudin (View Usage). After Lepirudin was administered, patient had the following side effects: cerebral haemorrhage, convulsion. Lepirudin dosage: 0.0225 Mg/kg/hr.

4748530-7 | Activated Partial Thromboplastin Time Prolonged, Oesophageal Haemorrhage
Patient was taking Lepirudin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, oesophageal haemorrhage on Aug 18, 2005 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 165.3 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia and. Lepirudin dosage: Titrated Continuous Infusion Intravenous. Patient was hospitalized.